|
biomedicina slovenica |
pr=Clemons : 6
-
Vardy J. L.; Pond Gregory Russell; Dodd Anna; Warr David; Šeruga Boštjan; Clemons Mark J.; Bordeleau Louise; Tannock Ian
A randomized, double-blind, placebo-controlled cross over trial of the effect on quality of life (QOL) of continuing dexamethasone beyond 24 hours following moderately emetogenic chemotherapy in women with breast cancer
2011 ►
-
Vardy JL; Pond Gregory Russell; Dodd Anna; Warr David; Šeruga Boštjan; Clemons Mark J; Bordeleau Louise; Goodwin Peter C; Tannock Ian
A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer
2012 ►
-
Amir Eitan; Šeruga Boštjan; Freedman Orit; Clemons Mark
Amenorrhoea, menopause, and endocrine therapy for breast cancer
2009 ►
-
Amir Eitan; Ocaña Alberto; Freedman Orit; Clemons Mark; Šeruga Boštjan
Dose-dense treatment for triple-negative breast cancer: chemotherapy
2010 ►
-
Amir Eitan; Ocaña Alberto; Šeruga Boštjan; Josse Robert; Clemons Mark
Zoledronic acid for breast cancer therapy-induced bone loss: medical oncology
2010 ►
-
Amir Eitan; Ocaña Alberto; Šeruga Boštjan; Freedman Orit; Clemons Mark
Lapatinib and HER2 status: results of a meta-analysis of randomized phase III trials in metastatic breast cancer
2010 ►
New search
Comments
Top of page
Institute for Biostatistics and Medical Informatics